» Articles » PMID: 28666590

Regulation of DNA Damage Tolerance in Mammalian Cells by Post-translational Modifications of PCNA

Overview
Journal Mutat Res
Publisher Elsevier
Specialty Genetics
Date 2017 Jul 2
PMID 28666590
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

DNA damage tolerance pathways, which include translesion DNA synthesis (TLS) and template switching, are crucial for prevention of DNA replication arrest and maintenance of genomic stability. However, these pathways utilize error-prone DNA polymerases or template exchange between sister DNA strands, and consequently have the potential to induce mutations or chromosomal rearrangements. Post-translational modifications of proliferating cell nuclear antigen (PCNA) play important roles in controlling these pathways. For example, TLS is mediated by mono-ubiquitination of PCNA at lysine 164, for which RAD6-RAD18 is the primary E2-E3 complex. Elaborate protein-protein interactions between mono-ubiquitinated PCNA and Y-family DNA polymerases constitute the core of the TLS regulatory system, and enhancers of PCNA mono-ubiquitination and de-ubiquitinating enzymes finely regulate TLS and suppress TLS-mediated mutagenesis. The template switching pathway is promoted by K63-linked poly-ubiquitination of PCNA at lysine 164. Poly-ubiquitination is achieved by a coupled reaction mediated by two sets of E2-E3 complexes, RAD6-RAD18 and MMS2-UBC13-HTLF/SHPRH. In addition to these mono- and poly-ubiquitinations, simultaneous mono-ubiquitinations on multiple units of the PCNA homotrimeric ring promote an unidentified damage tolerance mechanism that remains to be fully characterized. Furthermore, SUMOylation of PCNA in mammalian cells can negatively regulate recombination. Other modifications, including ISGylation, acetylation, methylation, or phosphorylation, may also play roles in DNA damage tolerance and control of genomic stability.

Citing Articles

The USP1 Inhibitor KSQ-4279 Overcomes PARP Inhibitor Resistance in Homologous Recombination-Deficient Tumors.

Cadzow L, Brenneman J, Tobin E, Sullivan P, Nayak S, Ali J Cancer Res. 2024; 84(20):3419-3434.

PMID: 39402989 PMC: 11474170. DOI: 10.1158/0008-5472.CAN-24-0293.


RAD18- and BRCA1-dependent pathways promote cellular tolerance to the nucleoside analog ganciclovir.

Ahmad T, Kawasumi R, Hirota K Genes Cells. 2024; 29(11):935-950.

PMID: 39169841 PMC: 11555630. DOI: 10.1111/gtc.13155.


Simulating Space Conditions Evokes Different DNA Damage Responses in Immature and Mature Cells of the Human Hematopoietic System.

Handwerk L, Schreier H, Kraft D, Shreder K, Hemmersbach R, Hauslage J Int J Mol Sci. 2023; 24(18).

PMID: 37762064 PMC: 10531023. DOI: 10.3390/ijms241813761.


Novel mechanisms for the removal of strong replication-blocking HMCES- and thiazolidine-DNA adducts in humans.

Sugimoto Y, Masuda Y, Iwai S, Miyake Y, Kanao R, Masutani C Nucleic Acids Res. 2023; 51(10):4959-4981.

PMID: 37021581 PMC: 10250235. DOI: 10.1093/nar/gkad246.


Arginine shortage induces replication stress and confers genotoxic resistance by inhibiting histone H4 translation and promoting PCNA polyubiquitination.

Wang Y, Kelso A, Karamafrooz A, Chen Y, Chen W, Cheng C bioRxiv. 2023; .

PMID: 36778247 PMC: 9915598. DOI: 10.1101/2023.01.31.526362.